FdaApplication

BLA 761369

Back to search

Identifiers

Properties

PropertyValue
applicant_namePfizer Inc.
application_typeBLA
approval_date2024-10-11

Products (4)

ProductActive ingredientStrengthDosage form
HYMPAVZIMARSTACIMAB-HNCQ150MG/MLInjection
HYMPAVZI—75MG/0.5MLInjection
HYMPAVZI—75MG/0.5MLInjection
HYMPAVZI—150MG/MLInjection

4 products